We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 28

The case of ophthalmic drugs in Italy and France: a lesson to learn - parallel antitrust investigations and cooperation between national competition authorities
  • McDermott Will & Emery
  • European Union, France, Italy
  • May 7 2014

The recent investigations into two pharmaceutical companies active in the ophthalmic drugs market in Italy and France serve as a reminder of the


Pharmacist order challenges Commission’s power of investigation
  • McDermott Will & Emery
  • European Union, France
  • February 6 2009

The French National Pharmacist Order has launched a challenge before the European Court of First Instance against the European Commission's powers of investigation in competition cases


GlaxoSmithKline infringed competition rules by restricting parallel trade
  • McDermott Will & Emery
  • European Union, Greece
  • April 4 2008

Advocate General Ruiz-Jarabo has delivered a non-binding opinion to the European Court of Justice (ECJ), finding that GlaxoSmithKline Plc (GSK) abused its dominant position by limiting distribution of certain pharmaceuticals to Greek wholesalers


The extent of supply limitation on EU pharmaceutical trade
  • McDermott Will & Emery
  • European Union
  • December 16 2008

In its 16 September 2008 judgment, the European Court of Justice (ECJ) gave further guidance on how a dominant pharmaceutical supplier can justify limiting supplies to wholesalers


Matthew Kopetski
  • McDermott Will & Emery


Andrea L. Hamilton
  • McDermott Will & Emery

Keo Shaw
  • McDermott Will & Emery

Laurent Ayache
  • McDermott Will & Emery

Joseph F. Winterscheid
  • McDermott Will & Emery